// App-Quantinova.ai

417 : Contribution of Pain Relief to Function, Fatigue, and Quality of Life When Inflammation Is Controlled in Patients with Rheumatoid Arthritis

Researchers

Presenter

  • Janet Pope

Principal Investigators

  • Yvonne Lee

  • Bruno Fautrel

  • Kei Ikeda

  • Amanda Quebe

  • Xiang Zhang

  • Carol Gaich

  • Francesco De Leonardis

  • Jeffrey Lisse

  • Jennifer Workman

  • Roy Fleischmann

  • Mark Genovese

  • Peter Taylor

Medical Centers

  • Arthritis Centre Twente, Enschede, Netherlands

  • Western Univeristy, London, ON, Canada

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

  • Pitié-Salpêtrière Hospital, Department of Rheumatology, AP-HP, Sorbonne University, UPMC university, Paris, Ile-de-France, France

  • Chiba University Hospital, Chiba, Japan

  • Eli Lilly and Company, Indianapolis, IN

  • Metroplax Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX

  • University of Oxford, Oxford, United Kingdom

Locations

  • Netherlands

  • Canada

  • France

  • Japan

  • United States

  • United Kingdom

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • C reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved